E-DRUG: WHO consultation on ensuring balanced national policies for access and safe use of controlled medicines
-----------------------------------------
Dear e-druggers,
WHO is embarking on the revision of the 2011 WHO guidance document "Ensuring balance in national policies on controlled substances: Guidance for availability and accessibility of controlled medicines."
This guidance document will be revised in light of new scientific evidence that has emerged since the publication of the 2011 document and out of consideration of WHO's new policies for the management of conflicts of interest that have been in place since 2014. The revision of this guidance document will be carried out in accordance with WHO guidance on the development of evidence-based guidelines.
The new guideline will assist policy makers as well as programme managers and experts in countries in the formulation and implementation of balanced policies to ensure access to and safe use of controlled medicines while preventing their diversion, misuse and harm to health.
As part of the revision of this document, WHO is carrying out a public consultation on the scope of the guideline on 19 February 2020 at 14:00 CET.
Please find attached in the link below information on the scoping document for the new guideline and the list of experts considered for the Guideline Development Group.
https://origin.who.int/medicines/access/controlled-substances/controlled_medicines_access/en/
Best regards,
Dr Gilles Forte
Coordinator
Office of the Assistant Director General
Access to Medicines, Vaccines and Pharmaceuticals (MVP)
World Health Organization
Geneva, Switzerland
Office: +41 (0)22 791 3617
Mobile: +41 (0)79 2493544
Email: forteg@who.int
Web: http://www.who.int/medicines/en/